Abstract: The present invention provides nucleic acid constructs that encode fusion peptides comprising a bioluminescent protein and a precursor of a secreted peptide or protein expressed at the cell surface and high throughput screening assays using same.
Type:
Grant
Filed:
May 19, 2017
Date of Patent:
August 6, 2019
Assignees:
THE BROAD INSTITUE, INC., THE GENERAL HOSPITAL CORPORATION, INSTITUTO CARLOS SLIM DE LA SALUD, A.C.
Inventors:
Sean Burns, David Altshuler, Amedeo Vetere